Easy Identification of Leishmania Species by Mass Spectrometry

PLoS Neglected Tropical Diseases

Volumn 8, Issue 6, 2014, Pages

  Mouri, Oussama ^a   Morizot, Gloriat ^b   Van der Auwera, Gert ^c   Ravel, Christophe ^d   Passet, Marie ^a   Chartrel, Nathalie ^a   Joly, Isabelle ^a   Thellier, Marc ^a,e,f   Jauréguiberry, Stéphane ^a,e   Caumes, Eric ^a,e   Mazier, Dominique ^a,e,f   Marinach Patrice, Carine ^e,f   Buffet, Pierre ^a,e,f  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d Centre National de Référence des Leishmanioses   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70;

ALGORITHM; ARTICLE; CLUSTER ANALYSIS; LEISHMANIA; LEISHMANIASIS; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIAL IDENTIFICATION; MICROBIOLOGICAL EXAMINATION; MOLECULAR BIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PARASITE CULTURE; PARASITE ISOLATION; PARASITOLOGY; PHYLOGENY; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; STRAIN IDENTIFICATION; ADOLESCENT; ADULT; AGED; CHEMISTRY; CHILD; CLASSIFICATION; COMPARATIVE STUDY; DIAGNOSTIC PROCEDURE; EVALUATION STUDY; FEMALE; FRANCE; HUMAN; ISOLATION AND PURIFICATION; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; PROCEDURES; TIME; TRAVEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CLINICAL LABORATORY TECHNIQUES; FEMALE; FRANCE; HUMANS; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; PARASITOLOGY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS; TRAVEL; YOUNG ADULT;

EID: 84903453845     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002841     Document Type: Article

References (39)

1. Herwaldt BL, Arana BA, Navin TR, (1992) The natural history of cutaneous leishmaniasis in Guatemala. Journal of Infectious Diseases 165: 518-527.
2. Buffet P, (2012) [Cutaneous leishmaniasis: can the infective agent be determined on clinical grounds alone?]. Ann Dermatol Venereol 139: 515-517.
3. Morizot G, Kendjo E, Mouri O, Thellier M, Perignon A, et al. (2013) Travelers With Cutaneous Leishmaniasis Cured Without Systemic Therapy. Clin Infect Dis 57: 370-80.
4. Neal RA, Allen S, McCoy N, Olliaro P, Croft SL, (1995) The sensitivity of Leishmania species to aminosidine. J Antimicrob Chemother 35: 577-584.
5. Blum J, Lockwood DNJ, Visser L, Harms G, Bailey MS, et al. (2012) Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis. International Health 4: 153-163.
6. WHO (2011) Control of the leishmaniases:report of a meeting of the WHO Expert Committee on the control of leishmaniases, Geneva, 22-26 March 2010. WHO Technical Report series 949: 1-185.
7. Buffet PA, Rosenthal E, Gangneux JP, Lightburne E, Couppie P, et al. [Therapy of leishmaniasis in France: consensus on proposed guidelines]. Presse Med 40: 173-184.
8. Modabber F, Buffet PA, Torreele E, Milon G, Croft SL, (2007) Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006. Kinetoplastid Biol Dis 6: 3.
9. Navin TR, Arana BA, Arana FE, Berman JD, Chajon JF, (1992) Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 165: 528-534.
10. Arevalo J, Ramirez L, Adaui V, Zimic M, Tulliano G, et al. (2007) Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J Infect Dis 195: 1846-1851.
11. Pratlong F, Dereure J, Ravel C, Lami P, Balard Y, et al. (2009) Geographical distribution and epidemiological features of Old World cutaneous leishmaniasis foci, based on the isoenzyme analysis of 1048 strains. Trop Med Int Health 14: 1071-1085.
12. Chouicha N, Lanotte G, Pratlong F, Cuba Cuba CA, Velez ID, et al. (1997) Phylogenetic taxonomy of Leishmania (Viannia) braziliensis based on isoenzymatic study of 137 isolates. Parasitology 115 (Pt 4) (): 343-348.
13. Saravia NG, Segura I, Holguin AF, Santrich C, Valderrama L, et al. (1998) Epidemiologic, genetic, and clinical associations among phenotypically distinct populations of Leishmania (Viannia) in Colombia. American Journal of Tropical Medicine and Hygiene 59: 86-94.
14. Rotureau B, Ravel C, Couppie P, Pratlong F, Nacher M, et al. (2006) Use of PCR-restriction fragment length polymorphism analysis to identify the main new world Leishmania species and analyze their taxonomic properties and polymorphism by application of the assay to clinical samples. J Clin Microbiol 44: 459-467.
15. Montalvo Alvarez AM, Nodarse JF, Goodridge IM, Fidalgo LM, Marin M, et al. Differentiation of Leishmania (Viannia) panamensis and Leishmania (V.) guyanensis using BccI for hsp70 PCR-RFLP. Trans R Soc Trop Med Hyg 104: 364-367.
16. Montalvo AM, Fraga J, Monzote L, Montano I, De Doncker S, et al. Heat-shock protein 70 PCR-RFLP: a universal simple tool for Leishmania species discrimination in the New and Old World. Parasitology 137: 1159-1168.
17. Foulet F, Botterel F, Buffet P, Morizot G, Rivollet D, et al. (2007) Detection and identification of Leishmania species from clinical specimens by using a real-time PCR assay and sequencing of the cytochrome B gene. J Clin Microbiol 45: 2110-2115.
18. Marinach-Patrice C, Lethuillier A, Marly A, Brossas JY, Gene J, et al. (2009) Use of mass spectrometry to identify clinical Fusarium isolates. Clin Microbiol Infect 15: 634-642.
19. Marinach-Patrice C, Fekkar A, Atanasova R, Gomes J, Djamdjian L, et al. (2010) Rapid species diagnosis for invasive candidiasis using mass spectrometry. PLoS ONE 5: e8862.
20. Buchan BW, Ledeboer NA, (2013) Advances in identification of clinical yeast isolates by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 51: 1359-1366.
21. Bizzini A, Greub G, (2010) Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification. Clin Microbiol Infect 16: 1614-1619.
22. Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, et al. (2009) Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 49: 543-551.
23. Seng P, Abat C, Rolain JM, Colson P, Lagier JC, et al. (2013) Identification of rare pathogenic bacteria in a clinical microbiology laboratory: impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 51: 2182-2194.
24. Morizot G, Delgiudice P, Caumes E, Laffitte E, Marty P, et al. (2007) Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution? Am J Trop Med Hyg 76: 48-52.
25. Buffet PA, Sulahian A, Garin YJ, Nassar N, Derouin F, (1995) Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother 39: 2167-2168.
26. El Baidouri F, Diancourt L, Berry V, Chevenet F, Pratlong F, et al. (2013) Genetic Structure and Evolution of the Leishmania Genus in Africa and Eurasia: What Does MLSA Tell Us. PLoS Negl Trop Dis 7: e2255.
27. Shao C, Tian Y, Dong Z, Gao J, Gao Y, et al. (2012) The Use of Principal Component Analysis in MALDI-TOF MS: a Powerful Tool for Establishing a Mini-optimized Proteomic Profile. Am J Biomed Sci 4: 85-101.
28. Cnudde F, Raccurt C, Boulard F, Terron-Aboud B, Nicolas M, et al. (1994) Diffuse cutaneous leishmaniasis with visceral dissemination in an AIDS patient in Guadeloupe, West Indies. Aids 8: 559-560.
29. Dedet JP, Roche B, Pratlong F, Cales-Quist D, Jouannelle J, et al. (1995) Diffuse cutaneous infection caused by a presumed monoxenous trypanosomatid in a patient infected with HIV. Trans R Soc Trop Med Hyg 89: 644-646.
30. Navin TR, Arana BA, Arana FE, de Merida AM, Castillo AL, et al. (1990) Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Am J Trop Med Hyg 42: 43-50.
31. Arana BA, Mendoza CE, Rizzo NR, Kroeger A, (2001) Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. Am J Trop Med Hyg 65: 466-470.
32. Blum JA, Hatz CF, (2009) Treatment of cutaneous leishmaniasis in travelers 2009. J Travel Med 16: 123-131.
33. Romero GAS, Guerra MVD, Paes MG, Macedo VD, (2001) Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) Guyanensis in Brazil: Therapeutic response to meglumine antimoniate. American Journal of Tropical Medicine and Hygiene 65: 456-465.
34. Andersen EM, Cruz-Saldarriaga M, Llanos-Cuentas A, Luz-Cjuno M, Echevarria J, et al. (2005) Comparison of meglumine antimoniate and pentamidine for Peruvian cutaneous leishmaniasis. American Journal of Tropical Medicine and Hygiene 72: 133-137.
35. Soto J, Buffet P, Grogl M, Berman J, (1994) Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine. Am J Trop Med Hyg 50: 107-111.
36. Andersen EM, Cruz-Saldarriaga M, Llanos-Cuentas A, Luz-Cjuno M, Echevarria J, et al. (2005) Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis. Am J Trop Med Hyg 72: 133-137.
37. Ben Salah A, Ben Messaoud N, Guedri E, Zaatour A, Ben Alaya N, et al. (2013) Topical paromomycin with or without gentamicin for cutaneous leishmaniasis. N Engl J Med 368: 524-532.
38. Ben Salah A, Buffet PA, Morizot G, Ben Massoud N, Zaatour A, et al. (2009) WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study. PLoS Negl Trop Dis 3: e432.
39. Graca GC, Volpini AC, Romero GA, Oliveira Neto MP, Hueb M, et al. (2012) Development and validation of PCR-based assays for diagnosis of American cutaneous leishmaniasis and identification of the parasite species. Mem Inst Oswaldo Cruz 107: 664-674.